LIAISON® MEASLES IGG - COFEPRIS Registration 1581R2018 SSA
Access comprehensive regulatory information for LIAISON® MEASLES IGG (LIAISON® MEASLES IGG) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 1581R2018 SSA and manufactured by DIASORIN MÉXICO, S.A. DE C.V.. The device was registered on June 19, 2018.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.
EL ENSAYO LIAISON® MEASLES IGG EMPLEA LA TECNOLOGÍA DE LA QUIMIOLUMINISCENCIA (CLIA) PARA LA DETERMINACIÓN SEMICUANTITATIVA DE ANTICUERPOS IGG ESPECÍFICOS CONTRA EL VIRUS DEL SARAMPIÓN EN MUESTRAS DE SUERO O PLASMA HUMANO. ESTÁ DISEÑADO PARA FACILITAR LA
THE LIAISON® MEASLES IGG ASSAY EMPLOYS CHEMILUMINESCENCE TECHNOLOGY (CLIA) FOR THE SEMI-QUANTITATIVE DETERMINATION OF SPECIFIC IGG ANTIBODIES AGAINST MEASLES VIRUS IN HUMAN SERUM OR PLASMA SAMPLES. IT IS DESIGNED TO FACILITATE